REG - GlaxoSmithKline PLC - Director/PDMR Shareholding

GSKAnnouncement

05/03/2019 17:20

RNS Number : 9402R
GlaxoSmithKline PLC
05 March 2019
 


GlaxoSmithKline plc (the 'Company')
 
Transaction notification
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr B McNamara




b)


Position/status


CEO, GSK Consumer Healthcare




c)


Initial notification/
amendment


Initial Notification




2.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial  instrument


American Depositary Shares ('ADSs')
 
ISIN: US37733W1053
 




b)


Nature of the transaction


Cash payout of £270,644.71 less applicable tax withholding in respect of 6,700.785 notional ADS following vesting of an award made on 2 March 2015 under the GlaxoSmithKline Deferred Investment Award plan.




c)


Price(s) and volume(s)


 


Price(s)


Volume(s)


 




 


 $40.39
 


 6,700.785


 




 


 


 


 




d)


Aggregated information


n/a (single transaction)




Aggregated volume Price


 




e)


Date of the transaction


2019-03-04




f)


Place of the transaction
 


n/a




 
 
 
 
 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDELFBKXFFBBD